Atypical chemokine receptor 3

[1]. Ulrike Naumann, et al. CXCR7 functions as a scavenger for CXCL12 and CXCL11. PLoS One. 2010 Feb 11;5(2):e9175. [Content Brief]

[2]. Lorena Sánchez-Martín, et al. CXCR7 impact on CXCL12 biology and disease. Trends Mol Med. 2013 Jan;19(1):12-22. [Content Brief]

[3]. Irina Kalatskaya, et al. AMD3100 is a CXCR7 ligand with allosteric agonist properties. Mol Pharmacol. 2009 May;75(5):1240-7. [Content Brief]

[4]. Paramita Ray, et al. Carboxy-terminus of CXCR7 regulates receptor localization and function. Int J Biochem Cell Biol. 2012 Apr;44(4):669-78. [Content Brief]

[5]. Angélique Levoye, et al. CXCR7 heterodimerizes with CXCR4 and regulates CXCL12-mediated G protein signaling. Blood. 2009 Jun 11;113(24):6085-93. [Content Brief]

[6]. Mary C Whitman, et al. Decreased ACKR3 (CXCR7) function causes oculomotor synkinesis in mice and humans. Hum Mol Genet. 2019 Sep 15;28(18):3113-3125. [Content Brief]

[7]. Sudarshan Rajagopal, et al. Beta-arrestin- but not G protein-mediated signaling by the "decoy" receptor CXCR7. Proc Natl Acad Sci U S A. 2010 Jan 12;107(2):628-32. [Content Brief]

[8]. Karl Balabanian, et al. The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes. J Biol Chem. 2005 Oct 21;280(42):35760-6. [Content Brief]

[9]. Kirsten Hattermann, et al. The chemokine receptor CXCR7 is highly expressed in human glioma cells and mediates antiapoptotic effects. Cancer Res. 2010 Apr 15;70(8):3299-308. [Content Brief]

[10]. Jennifer M Burns, et al. A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development. J Exp Med. 2006 Sep 4;203(9):2201-13. [Content Brief]

[11]. Brian A Zabel, et al. Elucidation of CXCR7-mediated signaling events and inhibition of CXCR4-mediated tumor cell transendothelial migration by CXCR7 ligands. J Immunol. 2009 Sep 1;183(5):3204-11. [Content Brief]

[12]. Frederic Sierro, et al. Disrupted cardiac development but normal hematopoiesis in mice deficient in the second CXCL12/SDF-1 receptor, CXCR7. Proc Natl Acad Sci U S A. 2007 Sep 11;104(37):14759-64. [Content Brief]

[13]. Maciej Tarnowski, et al. CXCR7: a new SDF-1-binding receptor in contrast to normal CD34(+) progenitors is functional and is expressed at higher level in human malignant hematopoietic cells. Eur J Haematol. 2010 Dec;85(6):472-83. [Content Brief]

[14]. Tanja Nicole Hartmann, et al. A crosstalk between intracellular CXCR7 and CXCR4 involved in rapid CXCL12-triggered integrin activation but not in chemokine-triggered motility of human T lymphocytes and CD34+ cells. J Leukoc Biol. 2008 Oct;84(4):1130-40. [Content Brief]